what is glp 1 vs tirzepatide vs. Semaglutide: Key Differences & Benefits GLP-1 vs. GLP-1 + GIP:

Changes in Coagulation Factors Semaglutide, the active ingredient in Ozempic, may indirectly influence coagulation pathways

Nevertheless, the data sheets of several GLP-1 RAs do not recommend their administration to patients with severe gastrointestinal disease due to the limited experience in managing this condition

Having the wrong ingredients, or no ingredients, makes it impossible

Guidance Q1 Revenue : $600M to $625M (+2% to 7% YoY) Q1 Adjusted EBITDA : $35M to $55M (6% to 9% Margin) FY2026 Revenue : $2.7B to $2.9B (+15% to 24% YoY) FY2026 Adjusted EBITDA : $300M - $375M (11% to 13% Margin) There are a few problems with this guidance

However, the timeline for noticeable effects varies

These fake products, which may be circulating in the market without proper authorization, pose significant health risks due to the potential lack of active ingredients, incorrect dosages, or the presence of harmful substances